You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

Article metrics

Article menu
XML
Rheumatology
Protocol
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

 

Online download statistics by month:

Online download statistics by month: March 2021 to May 2022

AbstractFullPdf
Mar 202126426382
Apr 2021757440
May 202113413034
Jun 2021979833
Jul 202112312227
Aug 2021434219
Sep 2021434319
Oct 2021605855
Nov 2021646142
Dec 2021565523
Jan 2022475216
Feb 2022525226
Mar 2022383624
Apr 2022504716
May 2022353418
Total11811167474